vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and Ouster, Inc. (OUST). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $62.2M, roughly 2.0× Ouster, Inc.). On growth, Ouster, Inc. posted the faster year-over-year revenue change (106.6% vs 4.7%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $-37.2M). Over the past eight quarters, Ouster, Inc.'s revenue compounded faster (54.8% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.
NATR vs OUST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $62.2M |
| Net Profit | $4.1M | — |
| Gross Margin | 72.5% | 60.2% |
| Operating Margin | 4.3% | 1.5% |
| Net Margin | 3.3% | — |
| Revenue YoY | 4.7% | 106.6% |
| Net Profit YoY | 1379.4% | — |
| EPS (diluted) | $0.23 | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $62.2M | ||
| Q3 25 | $128.3M | $39.5M | ||
| Q2 25 | $114.8M | $35.0M | ||
| Q1 25 | $113.2M | $32.6M | ||
| Q4 24 | $118.2M | $30.1M | ||
| Q3 24 | $114.6M | $28.1M | ||
| Q2 24 | $110.6M | $27.0M | ||
| Q1 24 | $111.0M | $25.9M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $5.3M | $-21.7M | ||
| Q2 25 | $5.3M | $-20.6M | ||
| Q1 25 | $4.7M | $-22.0M | ||
| Q4 24 | $-321.0K | — | ||
| Q3 24 | $4.3M | $-25.6M | ||
| Q2 24 | $1.3M | $-23.9M | ||
| Q1 24 | $2.3M | $-23.8M |
| Q4 25 | 72.5% | 60.2% | ||
| Q3 25 | 73.3% | 42.1% | ||
| Q2 25 | 71.7% | 45.2% | ||
| Q1 25 | 72.1% | 41.3% | ||
| Q4 24 | 72.0% | 43.8% | ||
| Q3 24 | 71.3% | 38.3% | ||
| Q2 24 | 71.4% | 33.7% | ||
| Q1 24 | 71.2% | 28.6% |
| Q4 25 | 4.3% | 1.5% | ||
| Q3 25 | 7.0% | -61.4% | ||
| Q2 25 | 3.7% | -76.5% | ||
| Q1 25 | 5.4% | -73.0% | ||
| Q4 24 | 3.8% | -85.1% | ||
| Q3 24 | 4.6% | -98.0% | ||
| Q2 24 | 5.1% | -93.6% | ||
| Q1 24 | 4.2% | -99.5% |
| Q4 25 | 3.3% | — | ||
| Q3 25 | 4.2% | -55.0% | ||
| Q2 25 | 4.6% | -58.8% | ||
| Q1 25 | 4.2% | -67.5% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 3.8% | -91.1% | ||
| Q2 24 | 1.2% | -88.4% | ||
| Q1 24 | 2.1% | -91.9% |
| Q4 25 | $0.23 | $0.10 | ||
| Q3 25 | $0.30 | $-0.37 | ||
| Q2 25 | $0.28 | $-0.38 | ||
| Q1 25 | $0.25 | $-0.42 | ||
| Q4 24 | $-0.02 | $-0.46 | ||
| Q3 24 | $0.23 | $-0.54 | ||
| Q2 24 | $0.07 | $-0.53 | ||
| Q1 24 | $0.12 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $208.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $261.7M |
| Total Assets | $261.1M | $349.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $208.6M | ||
| Q3 25 | $95.6M | $244.5M | ||
| Q2 25 | $81.3M | $226.5M | ||
| Q1 25 | $86.5M | $168.2M | ||
| Q4 24 | $84.7M | $172.0M | ||
| Q3 24 | $78.7M | $151.4M | ||
| Q2 24 | $68.7M | $184.2M | ||
| Q1 24 | $77.8M | $187.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $261.7M | ||
| Q3 25 | $166.7M | $247.4M | ||
| Q2 25 | $163.7M | $221.0M | ||
| Q1 25 | $167.1M | $167.9M | ||
| Q4 24 | $161.0M | $180.9M | ||
| Q3 24 | $162.6M | $171.7M | ||
| Q2 24 | $156.4M | $170.6M | ||
| Q1 24 | $159.7M | $167.2M |
| Q4 25 | $261.1M | $349.5M | ||
| Q3 25 | $264.8M | $353.8M | ||
| Q2 25 | $254.9M | $321.8M | ||
| Q1 25 | $252.7M | $268.6M | ||
| Q4 24 | $240.9M | $276.1M | ||
| Q3 24 | $245.3M | $255.2M | ||
| Q2 24 | $235.8M | $309.9M | ||
| Q1 24 | $247.3M | $317.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $-15.4M |
| Free Cash FlowOCF − Capex | $7.6M | $-37.2M |
| FCF MarginFCF / Revenue | 6.1% | -59.8% |
| Capex IntensityCapex / Revenue | 1.9% | 35.0% |
| Cash ConversionOCF / Net Profit | 2.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $-64.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $-15.4M | ||
| Q3 25 | $18.5M | $-18.3M | ||
| Q2 25 | $4.3M | $-1.3M | ||
| Q1 25 | $2.6M | $-4.9M | ||
| Q4 24 | $12.2M | $-2.6M | ||
| Q3 24 | $9.6M | $-3.8M | ||
| Q2 24 | $1.3M | $-21.6M | ||
| Q1 24 | $2.2M | $-5.7M |
| Q4 25 | $7.6M | $-37.2M | ||
| Q3 25 | $16.8M | $-20.0M | ||
| Q2 25 | $3.0M | $-2.2M | ||
| Q1 25 | $1.5M | $-5.4M | ||
| Q4 24 | $10.0M | $-4.0M | ||
| Q3 24 | $7.9M | $-4.3M | ||
| Q2 24 | $-2.0M | $-22.0M | ||
| Q1 24 | $-1.5M | $-7.1M |
| Q4 25 | 6.1% | -59.8% | ||
| Q3 25 | 13.1% | -50.7% | ||
| Q2 25 | 2.6% | -6.3% | ||
| Q1 25 | 1.3% | -16.6% | ||
| Q4 24 | 8.5% | -13.3% | ||
| Q3 24 | 6.9% | -15.4% | ||
| Q2 24 | -1.9% | -81.5% | ||
| Q1 24 | -1.4% | -27.4% |
| Q4 25 | 1.9% | 35.0% | ||
| Q3 25 | 1.3% | 4.3% | ||
| Q2 25 | 1.2% | 2.5% | ||
| Q1 25 | 1.0% | 1.7% | ||
| Q4 24 | 1.9% | 4.8% | ||
| Q3 24 | 1.5% | 2.0% | ||
| Q2 24 | 3.0% | 1.3% | ||
| Q1 24 | 3.3% | 5.3% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
OUST
Segment breakdown not available.
